HeartSciences (HSCS) Cash & Equivalents Growth (1y) (2023 - 2026)
HeartSciences (HSCS) Cash & Equivalents Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 156.03% |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - | 30.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 30.83% |
| Oct 31, 2025 | -51.85% |
| Jul 31, 2025 | -35.66% |
| Apr 30, 2025 | -81.07% |
| Jan 31, 2025 | -63.31% |
| Oct 31, 2024 | 3,946.29% |
| Jul 31, 2024 | 653.89% |
| Apr 30, 2024 | 241.18% |
| Jan 31, 2024 | 266.48% |
| Oct 31, 2023 | -96.74% |
| Jul 31, 2023 | -86.53% |
| Apr 30, 2023 | 85.13% |